Site-Directed Protein Conjugation via N-Terminal Labeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing protein-nucleic acid conjugates have low conversion rates and produce significant by-products, leading to instability and functional impairment of the conjugates.
Innovation Solution
A protein moiety-linker conjugate is generated using a 2-picolinaldehyde derivative that specifically labels the nitrogen terminus of a protein, mediated by a polyhistidine tag and a maleimide derivative, to improve the synthesis of protein-active molecule conjugates with higher conversion rates and fewer by-products.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If 2-picolinaldehyde derivative is used for protein modification, then the modification can be performed, but the conversion rate is only about 50% and by-products are generated
Solution Approach 1:
The modification process is divided into two distinct stages: first forming a hydrazone intermediate between the 2-picolinaldehyde derivative and the N-terminus, then performing a second modification with a maleimide derivative. This segmentation allows each stage to be optimized independently, achieving over 80% overall conversion rate while reducing by-product formation through better control of reaction conditions at each step.
Solution Approach 2:
The N-terminus of the protein is pre-modified with a 2-picolinaldehyde derivative to form a stable hydrazone intermediate before introducing the maleimide derivative. This preliminary action creates a reactive site that enables subsequent high-efficiency modification while minimizing unwanted side reactions, as the intermediate is specifically positioned at the N-terminus.
2Productivity
If multiple addition reactions are performed to improve conversion, then conversion rate increases, but more by-products are generated and product stability decreases
Solution Approach 1:
A maleimide derivative is introduced as an intermediary reagent that reacts with the hydrazone intermediate formed at the N-terminus. This intermediary approach allows the modification to proceed through a controlled two-step mechanism, achieving high conversion rates while the maleimide group provides stable crosslinking that prevents degradation, reducing instability to less than 5% after 12 hours at 37°C.
3Ease of manufacture
If lysine residues are used for protein modification, then modification can be performed, but multiple site modifications occur and biological function changes
Solution Approach 1:
The modification is targeted specifically to the N-terminus of the protein using 2-picolinaldehyde derivatives that show high affinity for N-terminal amino groups. This local quality approach ensures that only the N-terminus is modified rather than multiple lysine residues throughout the protein, achieving site-specific modification with over 80% conversion rate while preserving biological function.
4Ease of manufacture
If cysteine residues are used for protein modification, then modification can be performed, but disulfide bond formation is disrupted and protein folding is affected
Solution Approach 1:
The N-terminus is pre-modified with 2-picolinaldehyde derivatives before introducing the maleimide derivative, creating a stable hydrazone intermediate. This preliminary action at the N-terminus avoids any interaction with cysteine residues and their disulfide bonds, preserving protein structure integrity while achieving high conversion rates through the subsequent maleimide modification.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a conversion rate of 80% or more and significantly improves the stability of the conjugates, maintaining site-directed conjugation and reducing degradation to less than 5%, compared to previous methods.
Implementation Method 1
a 2-picolinaldehyde derivative specifically labels the nitrogen terminus (N-terminus) of a protein
Implementation Method 2
a protein moiety-linker conjugate is generated as an intermediate under the mediation of a polyhistidine tag (His tag) located at the N-terminus and a maleimide derivative
Data Source
Figure 1~3
Figure 4~5
Figure 6~8
AI summary
Provided is a bioconjugation technique, specifically provided is a protein covalent modification technique, i.e., provided is a protein moiety-linker conjugate, which can be used as an intermediate for synthesizing a protein-active molecule conjugate. Further provided are a method for preparing the protein moiety-linker conjugate, and a method for synthesizing a protein-active molecule conjugate by means of using the protein moiety-linker conjugate as an intermediate. The method has a higher conversion rate and fewer by-products.